BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37715472)

  • 1. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Scobioala S; Parfitt R; Matulat P; Byrne J; Langer T; Troschel FM; Hesping AE; Clemens E; Kaatsch P; Grabow D; Kaiser M; Spix C; Kremer LC; Calaminus G; Baust K; Kuehni CE; Weiss A; Strebel S; Kuonen R; Elsner S; Haupt R; Garré ML; Gruhn B; Kepak T; Kepakova K; Winther JF; Kenborg L; Rechnitzer C; Hasle H; Kruseova J; Luks A; Lackner H; Bielack S; Beck JD; Jürgens H; van den Heuvel-Eibrink MM; Zolk O; Eich HT; Am Zehnhoff-Dinnesen A;
    Int J Cancer; 2024 Jan; 154(2):320-331. PubMed ID: 37715472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
    J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors.
    Merchant TE; Gould CJ; Xiong X; Robbins N; Zhu J; Pritchard DL; Khan R; Heideman RL; Krasin MJ; Kun LE
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1194-207. PubMed ID: 15001264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children.
    Keilty D; Khandwala M; Liu ZA; Papaioannou V; Bouffet E; Hodgson D; Yee R; Cushing S; Laperriere N; Ahmed S; Mabbott D; Ramaswamy V; Tabori U; Huang A; Bartels U; Tsang DS
    J Clin Oncol; 2021 Dec; 39(34):3813-3821. PubMed ID: 34570616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
    Bass JK; Hua CH; Huang J; Onar-Thomas A; Ness KK; Jones S; White S; Bhagat SP; Chang KW; Merchant TE
    J Clin Oncol; 2016 Apr; 34(11):1248-55. PubMed ID: 26811531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose.
    Hua C; Bass JK; Khan R; Kun LE; Merchant TE
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):892-9. PubMed ID: 18395355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
    Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
    Waissbluth S; Del Valle Á; Chuang A; Becker A
    Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
    Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
    Schuette A; Lander DP; Kallogjeri D; Collopy C; Goddu S; Wildes TM; Daly M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):106-112. PubMed ID: 31750863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
    Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
    Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
    Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensorineural hearing loss after radiotherapy for head and neck tumors: a prospective study of the effect of radiation.
    Yilmaz YF; Aytas FI; Akdogan O; Sari K; Savas ZG; Titiz A; Tumoz M; Unal A
    Otol Neurotol; 2008 Jun; 29(4):461-3. PubMed ID: 18520582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study.
    Apoorva KV; Vijendra Shenoy S; Athiyamaan MS; Kabekkodu S; Kshithi K; Zuturu N
    Am J Otolaryngol; 2023; 44(4):103914. PubMed ID: 37178536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
    Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
    Laver JH; Barredo JC; Amylon M; Schwenn M; Kurtzberg J; Camitta BM; Pullen J; Link MP; Borowitz M; Ravindranath Y; Murphy SB; Shuster J
    Leukemia; 2000 Mar; 14(3):369-73. PubMed ID: 10720128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
    Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
    Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
    Moxon-Emre I; Dahl C; Ramaswamy V; Bartels U; Tabori U; Huang A; Cushing SL; Papaioannou V; Laperriere N; Bouffet E; Mabbott DJ
    Cancer Med; 2021 Oct; 10(20):7111-7125. PubMed ID: 34480430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.